Due your Covid jab? Mind what you drink afterwards Moderate drinking is unlikely to impair your immune response, but heavy drinking might
about 4 hours ago Anahad O Connor
Covid shots: ‘If you are truly a moderate drinker, then there’s no risk of having a drink around the time of your vaccine,’ says virus researcher Ilhem Messaoudi. Photograph: Tony Cenicola/NYT
After a long year and a lot of anticipation, getting the Covid-19 vaccine can be cause for celebration – which might mean pouring a drink and toasting your new immunity. But can alcohol interfere with your immune response?
The short answer is that it depends on how much you drink. There is no evidence that having a drink or two can render any of the current coronavirus-disease vaccines less effective. Some studies have even found that, over the longer term, small or moderate amounts of alc
Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
You ve got your Covid vaccine. Can you have alcohol now?
SECTIONS
Share
iStock
Another reason to moderate your alcohol intake is that heavy drinking along with the hangover that can ensue can potentially amplify any side effects you might have from the COVID vaccine, including fever, malaise or body aches, and make you feel worse.
After a long year and a lot of anticipation, getting the COVID-19 vaccine can be cause for celebration, which for some might mean pouring a drink and toasting to their new immunity. But can alcohol interfere with your immune response?
The short answer is that it depends on how much you drink.
“The NCSI Study demonstrates the benefit of following a protocolized approach to AMICS, which includes early implantation of Impella. We are impressed with the improved survival rates seen with the use of best practices compared to the stagnant historical survival rate,” said Dr. Basir. “It is important to emphasize that the majority of hospitals in the NCSI Study were large community-based programs where heart attack patients first present. Giving these care teams a safe and effective protocol to manage critically ill patients has saved many lives.”
“NCSI is the largest prospective study of therapy for AMICS done in the U.S. in the last 20 years. We have found that the original observations from the Detroit Cardiogenic Shock Initiative have been reproduced showing significantly higher survival rates,” said William O’Neill, MD, medical director of the Henry Ford Health System Center for Structural Heart Disease and co-principal investigator of the study. “If implemen